Vaman Karma in Hyperacidity.

CLINICAL STUDY TO EVALUATE THE EFFICACY OF VAMAN KARMA AND DASHANG KWATH IN URDHWAG AMLAPITTA WITH SPECIAL REFERENCE TO HYPERACIDITY. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055446

Enrollment

Registered

2023-07-20

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K319- Disease of stomach and duodenum, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. PATIENT WILLING FOR TRAIL. 2. PATIENT WITH CARDINAL SYMPTONMS OF URDHWAGA AMLAPITTA. as- AVIPAKA (INDIGESTION), UTKLESHA (NAUSEA), TIKTA-AMLODGARA (ERUCTATION WITH BITTER AND SOUR TASTE), HRIT-KANTHADAHA (BURNING SENSATION IN THE CHEST AND THROAT), ARUCHI (LOSS OF TESTE), SHIRASHULA (HEADACHE), URAHSHULA (CHEST PAIN). 3. PATIENT BETWEEN AGE GROUP OF 18 YEARS TO 60 YEARS

Exclusion criteria

Exclusion criteria: 1. PATIENT BELOW AGE OF 18 YEARS AND ABOVE 60 YEARS 2. PATIENT WITH PAST HISTORY OF GASTROINTESTINAL SURGERY 3. ALREADY DIAGNOSED PATIENT OF CHRONIC DISEASES (CARDIOVESCULAR DISEASES, CANCER, DIABETES, ETC.) WITH EARLY OR LATE COMPLICATION. 4. ALL PATIENT WHICH IS CONTRAINDICATED FOR VAMAN KARMA AS DESCRIBED IN THE SAMHITA TEST.

Design outcomes

Primary

Measure	Time frame
MODERATE RELIEF IN SYMPTOMS AFTER 21 DAYSTimepoint: 21 DAYS	—

Secondary

Measure	Time frame
DECREASE IN DEPENDENCY OF REGULAR MEDICATION AFTER 35 DAYSTimepoint: 35th DAY	—

Countries

India

Contacts

Public ContactDR ABDUL VAHID

GOVERNMENT P.G. AYURVEDA COLLEGE AND HOSPITAL VARANASI

abdul.vahid025@gmail.com8755219068

Outcome results